Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study

References

• KesslerRCBirnbaumHGShahlyVAge differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey InitiativeDepress Anxiety201027435136420037917
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Study 2013 CollaboratorsGlobal, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013Lancet2015386999574380026063472
   PubMed Web of Science ®Google Scholar
• KesslerRCBerglundPDemlerOThe epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA2003289233095310512813115
   PubMed Web of Science ®Google Scholar
• McKnightPEKashdanTBThe importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment researchClin Psychol Rev200929324325919269076
   PubMed Web of Science ®Google Scholar
• KennedySHEisfeldBSCookeRGQuality of life: an important dimension in assessing the treatment of depression?J Psychiatry Neurosci200126SupplS23S2811590966
   PubMed Web of Science ®Google Scholar
• KatonWThe impact of depression on workplace functioning and disability costsAm J Manag Care20091511 SupplS322S32720088628
   PubMedGoogle Scholar
• KennedySHAndersenHFThaseMEEscitalopram in the treatment of major depressive disorder: a meta-analysisCurr Med Res Opin200925116117519210149
   PubMed Web of Science ®Google Scholar
• ThaseMEEntsuahARRudolphRLRemission rates during treatment with venlafaxine or selective serotonin reuptake inhibitorsBr J Psychiatry200117823424111230034
   PubMed Web of Science ®Google Scholar
• ThaseMEPritchettYLOssannaMJSwindleRWXuJDetkeMJEfficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorderJ Clin Psychopharmacol200727667267618004135
   PubMed Web of Science ®Google Scholar
• ThaseMEKornsteinSGGermainJMJiangQGuico-PabiaCNinanPTAn integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorderCNS Spectr200914314415419407711
   PubMed Web of Science ®Google Scholar
• ThaseMENierenbergAAVrijlandPvan OersHJSchutteAJSimmonsJHRemission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depressionInt Clin Psychopharmacol201025418919820531012
   PubMed Web of Science ®Google Scholar
• ThaseMEMahableshwarkarARDragheimMLoftHVietaEA meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adultsEur Neuropsychopharmacol201626697999327139079
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry2006163111905191717074942
   PubMed Web of Science ®Google Scholar
• WardenDRushAJTrivediMHFavaMWisniewskiSRThe STAR*D project results: a comprehensive review of findingsCurr Psychiatry Rep20079644945918221624
   PubMedGoogle Scholar
• KimJMKimSWStewartRPredictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND studyHum Psychopharmacol2011261415021344501
   PubMed Web of Science ®Google Scholar
• MauskopfJASimonGEKalsekarANimschCDunayevichECameronANonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorderDepress Anxiety2009261839718833573
   PubMed Web of Science ®Google Scholar
• ByfordSBarrettBDespiégelNWadeAImpact of treatment success on health service use and cost in depression: longitudinal database analysisPharmacoeconomics201129215717021142289
   PubMed Web of Science ®Google Scholar
• KubitzNMehraMPotluriRCGargNCossrowNCharacterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims databasePLoS One2013810e7688224204694
   PubMed Web of Science ®Google Scholar
• DennehyEBRobinsonRLStephensonJJImpact of non-remission of depression on costs and resource utilization: from the comorbidities and symptoms of depression (CODE) studyCurr Med Res Opin20153161165117725879140
   PubMed Web of Science ®Google Scholar
• JuddLLSchettlerPJRushAJA brief clinical tool to estimate individual patients’ risk of depressive relapse following remission: proof of conceptAm J Psychiatry2016173111140114627418380
   PubMed Web of Science ®Google Scholar
• TrivediMHRushAJWisniewskiSREvaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practiceAm J Psychiatry20061631284016390886
   PubMed Web of Science ®Google Scholar
• CheungAAnxiety as a predictor of treatment outcome in children and adolescents with depressionJ Child Adolesc Psychopharmacol201020321121620578934
   PubMed Web of Science ®Google Scholar
• BarkowKMaierWUstünTBGänsickeMWittchenHUHeunRRisk factors for depression at 12-month follow-up in adult primary health care patients with major depression: an international prospective studyJ Affect Disord2003761–315716912943946
   PubMed Web of Science ®Google Scholar
• WeinbergerMISireyJABruceMLHeoMPapademetriouEMeyersBSPredictors of major depression six months after admission for outpatient treatmentPsychiatr Serv200859101211121518832510
   PubMed Web of Science ®Google Scholar
• O’LearyDCostelloFGormleyNWebbMRemission onset and relapse in depression: an 18-month prospective study of course for 100 first admission patientsJ Affect Disord2000571–315917110708827
   PubMed Web of Science ®Google Scholar
• KatonWUnützerJRussoJMajor depression: the importance of clinical characteristics and treatment response to prognosisDepress Anxiety2010271192619798766
   PubMed Web of Science ®Google Scholar
• McGrathPJStewartJWQuitkinFMPredictors of relapse in a prospective study of fluoxetine treatment of major depressionAm J Psychiatry200616391542154816946178
   PubMed Web of Science ®Google Scholar
• ten DoesschateMCBocktingCLKoeterMWScheneAHPrediction of recurrence in recurrent depression: a 5.5-year prospective studyJ Clin Psychiatry201071898499120797379
   PubMed Web of Science ®Google Scholar
• NierenbergAAHusainMMTrivediMHResidual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D reportPsychol Med2010401415019460188
   PubMed Web of Science ®Google Scholar
• LamRWKennedySHMclntyreRSKhullarACognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatmentCan J Psychiatry2014591264965425702365
   PubMed Web of Science ®Google Scholar
• GondaXPompiliMSerafiniGCarvalhoAFRihmerZDomePThe role of cognitive dysfunction in the symptoms and remission from depressionAnn Gen Psychiatry2015142726396586
   PubMed Web of Science ®Google Scholar
• KroenkeKSpitzerRLWilliamsJBThe PHQ-9: validity of a brief depression severity measureJ Gen Intern Med200116960661311556941
   PubMed Web of Science ®Google Scholar
• GuyWCGI: Clinical Global ImpressionsECDEU Assessment Manual for PsychopharmacologyRockville (MD)National Institute of Mental Health1976217222
   Google Scholar
• MontgomerySAAsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
   PubMed Web of Science ®Google Scholar
• SullivanJJEdgleyKDehouxEA survey of multiple sclerosis – part 1: perceived cognitive problems and compensatory strategy useCan J Rehabil19904299105
   Google Scholar
• National Multiple Sclerosis SocietyMultiple Sclerosis Quality of Life Inventory: A User’s ManualNew YorkNMSS1997
   Google Scholar
• HamiltonMThe assessment of anxiety states by ratingBr J Med Psychol1959321505513638508
   PubMed Web of Science ®Google Scholar
• SheehanDVHarnett-SheehanKRajBAThe measurement of disabilityInt Clin Psychopharmacol199611Suppl 38995
   PubMed Web of Science ®Google Scholar
• ReillyMCZbrozekASDukesEMThe validity and reproducibility of a work productivity and activity impairment instrumentPharmacoeconomics19934535336510146874
   PubMed Web of Science ®Google Scholar
• WareJJrKosinskiMKellerSDA 12-item short-form health survey: construction of scales and preliminary tests of reliability and validityMed Care19963432202338628042
   PubMed Web of Science ®Google Scholar
• EuroQol GroupEuroQol: a new facility for the measurement of health-related quality of lifeHealth Policy199016319920810109801
   PubMed Web of Science ®Google Scholar
• McGahueyCAGelenbergAJLaukesCAThe Arizona Sexual Experience Scale (ASEX): reliability and validityJ Sex Marital Ther2000261254010693114
   PubMed Web of Science ®Google Scholar
• MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
   PubMed Web of Science ®Google Scholar
• HawleyCJGaleTMSivakumaranTDefining remission by cut off score on the MADRS: selecting the optimal valueJ Affect Disord200272217718412200208
   PubMed Web of Science ®Google Scholar
• ZimmermanMPosternakMAChelminskiIDerivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depressionJ Psychiatr Res200438657758215458853
   PubMed Web of Science ®Google Scholar
• DunlopBWLiTKornsteinSGConcordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorderJ Psychiatr Res20114519610320537348
   PubMed Web of Science ®Google Scholar
• FrankEPrienRFJarrettRBConceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrenceArch Gen Psychiatry19914898518551929776
   PubMed Web of Science ®Google Scholar
• GeddesJRCarneySMDaviesCRelapse prevention with antidepressant drug treatment in depressive disorders: a systematic reviewLancet2003361935865366112606176
   PubMed Web of Science ®Google Scholar
• SpijkerJBijlRVde GraafRNolenWADeterminants of poor 1-year outcome of DSM-III-R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS)Acta Psychiatr Scand2001103212213011167315
   PubMed Web of Science ®Google Scholar
• KloiberSIsingMReppermundSOverweight and obesity affect treatment response in major depressionBiol Psychiatry200762432132617241618
   PubMed Web of Science ®Google Scholar
• FavaMWiltseCWalkerDBrechtSChenAPerahiaDPredictors of relapse in a study of duloxetine treatment in patients with major depressive disorderJ Affect Disord2009113326327118625521
   PubMed Web of Science ®Google Scholar
• RucciPFrankECalugiSIncidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combinationDepress Anxiety2011281195596221898715
   PubMed Web of Science ®Google Scholar
• NordenskjöldAvon KnorringLEngströmIPredictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: a population-based cohort studyDepress Res Treat2011201147098522110913
   PubMedGoogle Scholar
• TrinhNHShyuIMcGrathPJExamining the role of race and ethnicity in relapse rates of major depressive disorderCompr Psychiatry201152215115521295221
   PubMed Web of Science ®Google Scholar
• McGrathPJStewartJWPetkovaEPredictors of relapse during fluoxetine continuation or maintenance treatment of major depressionJ Clin Psychiatry200061751852410937611
   PubMed Web of Science ®Google Scholar
• AngstmanKBShippeeNDMaclaughlinKLPatient self-assessment factors predictive of persistent depressive symptoms 6 months after enrollment in collaborative care managementDepress Anxiety201330214314823139162
   PubMed Web of Science ®Google Scholar
• WangJLPattenSBCurrieSSareenJSchmitzNPredictors of 1-year outcomes of major depressive disorder among individuals with a lifetime diagnosis: a population-based studyPsychol Med201242232733421740627
   PubMed Web of Science ®Google Scholar
• PapakostasGILarsenKTesting anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopramEur Arch Psychiatry Clin Neurosci2011261314715620859636
   PubMed Web of Science ®Google Scholar
• KessingLVSubtypes of depressive episodes according to ICD-10: prediction of risk of relapse and suicidePsychopathology200336628529114646451
   PubMed Web of Science ®Google Scholar
• JangSJungSPaeCKimberlyBPNelsonJCPatkarAAPredictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS)J Affect Disord2013151385485924021959
   PubMed Web of Science ®Google Scholar
• YangHChuziSSinicropi-YaoLType of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetineEur Arch Psychiatry Clin Neurosci2010260214515019572158
   PubMed Web of Science ®Google Scholar
• SheetsESDuncanLEBjornssonASCraigheadLWCraigheadWEPersonality pathology factors predict recurrent major depressive disorder in emerging adultsJ Clin Psychol201470653654523852879
   PubMed Web of Science ®Google Scholar
• RiedelMMöllerHJObermeierMClinical predictors of response and remission in inpatients with depressive syndromesJ Affect Disord20111331–213714921555156
   PubMed Web of Science ®Google Scholar
• GopinathSKatonWJRussoJELudmanEJClinical factors associated with relapse in primary care patients with chronic or recurrent depressionJ Affect Disord20071011–3576317156852
   PubMed Web of Science ®Google Scholar
• ZimmermanMMcGlincheyJBPosternakMAFriedmanMBoerescuDAttiullahNRemission in depressed outpatients: more than just symptom resolution?J Psychiatr Res2008421079780117986389
   PubMed Web of Science ®Google Scholar
• PaykelESRamanaRCooperZHayhurstHKerrJBarockaAResidual symptoms after partial remission: an important outcome in depressionPsychol Med1995256117111808637947
   PubMed Web of Science ®Google Scholar
• IshakWWGreenbergJMCohenRMPredicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression (IBI-D)J Affect Disord20131511596523790554
   PubMed Web of Science ®Google Scholar
• NovickDHongJMontgomeryWDueñasHGadoMHaroJMPredictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational studyNeuropsychiatr Dis Treat20151119720525653529
   PubMed Web of Science ®Google Scholar
• SeidmanSEjaculatory dysfunction and depression: pharmacological and psychobiological interactionsInt J Impot Res200618Suppl 1S33S3816953246
   PubMed Web of Science ®Google Scholar
• ClaytonAHEl HaddadSIluonakhamheJPPonce MartinezCSchuckAESexual dysfunction associated with major depressive disorder and antidepressant treatmentExpert Opin Drug Saf201413101361137425148932
   PubMed Web of Science ®Google Scholar
• AshtonAKJamersonBDWeinsteinWLWagonerCAntidepressant-related adverse effects impacting treatment compliance: results of a patient surveyCurr Ther Res Clin Exp20056629610624672116
   PubMed Web of Science ®Google Scholar
• WhismanMADepression and marital distress: findings from clinical and community studiesBeachSRMarital and Family Processes in DepressionWashingtonAmerican Psychological Association2001324
   Google Scholar
• WhismanMAMarital distress and DSM-IV psychiatric disorders in a population-based national surveyJ Abnorm Psychol2007116363864317696721
   PubMed Web of Science ®Google Scholar
• WhismanMAUebelackerLAProspective associations between marital discord and depressive symptoms in middle-aged and older adultsPsychol Aging200924118418919290750
   PubMed Web of Science ®Google Scholar
• JuddLLPaulusMJSchettlerPJDoes incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?Am J Psychiatry200015791501150410964869
   PubMed Web of Science ®Google Scholar
• BortolatoBCarvalhoAFMcIntyreRSCognitive dysfunction in major depressive disorder: a state-of-the-art clinical reviewCNS Neurol Disord Drug Targets201413101804181825470396
   PubMed Web of Science ®Google Scholar
• WooYSRosenblatJDKakarRBahkWMMcIntyreRSCognitive deficits as a mediator of poor occupational function in remitted major depressive disorder patientsClin Psychopharmacol Neurosci201614111626792035
   PubMed Web of Science ®Google Scholar
• KurianBTGreerTLTrivediMHStrategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptomsExpert Rev Neurother20099797598419589048
   PubMed Web of Science ®Google Scholar
• ZajeckaJKornsteinSGBlierPResidual symptoms in major depressive disorder: prevalence, effects, and managementJ Clin Psychiatry201374440741423656849
   PubMed Web of Science ®Google Scholar
• KhanAKhanSRShanklesEBPolissarNLRelative sensitivity of the Montgomery-Ǻsberg Depression Rating Scale, the Hamilton Depression Rating Scale and the Clinical Global Impressions Rating Scale in antidepressant clinical trialsInt Clin Psychopharmacol200217628128512409681
   PubMed Web of Science ®Google Scholar
• JiangQAhmedSAn analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorderAnn Gen Psychiatry20098419166588
   PubMedGoogle Scholar
• TrivediMHCorey-LislePKGuoZLennoxRDPikalovAKimERemission, response without remission, and nonresponse in major depressive disorder: impact on functioningInt Clin Psychopharmacol200924313313819318972
   PubMed Web of Science ®Google Scholar
• KatzelnickDJDuffyFFChungHRegierDARaeDSTrivediMHDepression outcomes in psychiatric clinical practice: using a self-rated measure of depression severityPsychiatr Serv201162892993521807833
   PubMed Web of Science ®Google Scholar
• GarrisonGMAngstmanKBO’ConnorSSWilliamsMDLineberryTWTime to remission for depression with collaborative care management (CCM) in primary careJ Am Board Fam Med2016291101726769872
   PubMed Web of Science ®Google Scholar
• McMillanDGilbodySRichardsDDefining successful treatment outcome in depression using the PHQ-9: a comparison of methodsJ Affect Disord20101271–312212920569992
   PubMed Web of Science ®Google Scholar
• ManeaLGilbodySMcMillanDOptimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysisCMAJ20121843E191E19622184363
   PubMed Web of Science ®Google Scholar
• EllKKatonWLeePJDepressive symptom deterioration among predominantly Hispanic diabetes patients in safety net carePsychosomatics201253434735522458987
   PubMed Web of Science ®Google Scholar
• HorneDKehlerSKaoukisGDepression before and after cardiac surgery: do all patients respond the same?J Thorac Cardiovasc Surg201314551400140623260432
   PubMed Web of Science ®Google Scholar